Differentiation between the effects of unprocessed portal blood and reduced liver function on brain indole amine metabolism in the portacaval shunted rat

Metabolic Brain Disease

Volumn 13, Issue 2, 1998, Pages 137-146

  Alexander, Barry ^a   Aslam, Mohammed ^b   Nobin, Anders ^c   Benjamin, Irving S ^a  

^a KING'S COLLEGE LONDON   (United Kingdom)

^b IMPERIAL COLLEGE LONDON   (United Kingdom)

^c LUND UNIVERSITY   (Sweden)

Author keywords

5 hydroxytryptamine; Blood brain barrier; Hepatic encephalopathy; Indoleamines; Portacaval anastomosis; Portacaval transposition

Indexed keywords

5 HYDROXYINDOLEACETIC ACID; 5 HYDROXYTRYPTOPHAN; INDOLEAMINE; SEROTONIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BRAIN METABOLISM; BRAIN STEM; CONTROLLED STUDY; HEPATIC ENCEPHALOPATHY; LIVER DYSFUNCTION; LIVER FAILURE; MALE; NONHUMAN; PORTAL VEIN BLOOD; PORTOCAVAL SHUNT; RAT;

ANIMALS; BODY WEIGHT; BRAIN; LIVER; MALE; PORTACAVAL SHUNT, SURGICAL; PORTAL SYSTEM; RATS; RATS, SPRAGUE-DAWLEY; SEROTONIN;

EID: 0031874124     PISSN: 08857490     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1020661230502     Document Type: Article

References (29)

1. Bengtsson, F., Gage, F.H., Jeppsson, B., Nobin, A. and Rosengren, E. (1985). Brain monoamine metabolism and behaviour in portacaval shunted rats. Exp. Neurol. 90:21-35.
2. Bengtsson, F., Bugge, M., Brun, A., Falck, B., Henriksson, K.G. and Nobin, A. (1988). The impact of time after portacaval shunt in the rat on behaviour, brain serotonin, and brain and muscle histology. J. Neurol. Sci. 83:109-122.
3. Bengtsson, F., Bugge, M., Johansen, K.H. and Butterworth, R.F. (1991). Brain tryptophan hydroxylation in the portacaval shunted rat: a hypothesis for the regulation of serotonin turnover in vivo. J. Neurochem. 56:1069-1074.
4. Benjamin, I.S., Ryan, C.J., Mclay, A.L., Hickmann, C.H.N. and Blumgart, L.H. (1976). The effects of portacaval shunting and transposition on serum IgG levels in the rat. Gastroenterology 70:661-664.
5. Benjamin, I.S., Ryan, C.J., Englebrecht, G.H.C., Campbell, J.A.H., Van Hoorn-Hickman, R. and Blumgart, L.H. (1984). Portacaval transposition in the rat: definition of a valuable model for hepatic research. Hepatology 4:704-708.
6. Bergeron, M., Swain, M., Reader, T.A., Grondin, L. and Butterworth, R.F. (1990). Effect of ammonia on brain serotonin metabolism in relation to function in the portacaval shunted rat. J. Neurochem. 55:222-229.
7. Bergvist, P.B.F., Hjorth, S., Apelqvist, G. and Bengtsson, F. (1996). Acute effects of L-tryptophan on brain extracellular 5-HT and 5-HIAA levels in chronic experimental portal-systemic encephalopathy. Metab. Brain Dis. 11:269-278.
8. Bergqvist, P.B.F., Some, M., Apelqvist, G., Helander, A. and Bengtsson, F. (1997). Elevated brain 5-hydroxytryptophol levels in experimental portal-systemic encephalopathy. Pharmacol. Toxicol. 80:187-190.
9. Butterworth, R.F. (1992). Pathogenesis and treatment of portal-systemic encephalopathy: an update. Dig. Dis. Sci. 37:321-327.
10. Carlsson, A. and Lindqvist, M. (1970). Accumulation of 5-hydroxytryptophan in mouse brain after decarboxylase inhibition. J. Pharm. Pharmacol. 22:726-727.
11. Child, C.G., Barr, D.P. and Holswade, C.S. (1953). Liver regeneration following portacaval transposition in dogs. Ann. Surg. 138:600-608.
12. Cooper, J.R., Bloom, F.E. and Roth, R.H. (1978). Metabolism and the central nervous system. In (J.R. Cooper, F.E. Bloom and R.H. Roth eds.), The biochemical basis of neuropharmacology, Ch 3; New York: Oxford University Press, pp. 47-59.
13. Doyle, D., Ryan, C.J., Benjamin, I.S. and Blumgart, L.H. (1978). Changes in the nuclei of astrocytes following portacaval shunting and portacaval transposition in the rat. Br. J. Exp. Pathol. 59:461-466.
14. Faraj, B.A., Camp, V.M., Ansley, J.D., Scott, J., Ali, P.M. and Malveaux, E.J. (1981). Evidence for central hypertyraminaemia in hepatic encephalopathy. J. Clin. Invest. 67:395-402.
15. Fischer J.E., Rosen, H.M., Ebeid A.M., James J.H., Keanel, J.M. and Soeters, P.B. (1976). Effect of normalisation of plasma amino acids on hepatic encephalopathy in man. Surgery 80:77-91.
16. Fischer, J.E. (1980). Hepatic encephalopathy - a unifying hypothesis. Nutr. Res. 38:371-373.
17. Fischer, J.E. (1982). Amino acids in hepatic coma. Dig. Dis. Sci. 27:97-102.
18. Jalan, R. and Hayes, P.C. (1997). Hepatic encephalopathy and ascites. Lancet, 350:1309-1315.
19. James, J.H., Ziparo, V., Jeppsson, B. and Fischer, J.E. (1979). Hyperammonemia, plasma amino acid imbalance and blood-brain amino acid transport: A unified theory of portal-systemic encephalopathy. Lancet 2:772-775.
20. Li, X., Benjamin, I.S. and Alexander, B. (1998). The relationship between intrahepatic portal systemic shunts and microsphere induced portal hypertension in the rat liver. Gut 42:276-282.
21. Lee, S. and Fisher, B. (1961). Portacaval shunt in the rat. Surgery 50:668-672.
22. Maddison, J.E., Watson W.E.J., Dodd, P.R. and Johnston, G.A.R. (1990). Plasma GABA-like activity in rats with hepatic encephalopathy is due to GABA and taurine. Hepatology 11:105-110.
23. Record, C.O. (1991). Neurochemistry of hepatic encephalopathy. Gut 32:1261-1263.
24. Riordan, S.M. and Williams, R. (1997). The treatment of hepatic encephalopathy. New Eng. J. Med. 337:473-479.
25. Ryan, C.J., Benjamin, I.S. and Blumgart, L.H. (1974). Portacaval transposition in the rat: a new technique and its effects on liver and body weight. Br. J. Surg. 61:224-228.
26. Ryan, C.J., Guest, J., Harper, A.M. and Blumgart, L.H. (1978). Hepatic blood flow studies in the rat before and after portacaval transposition. Br. J. Exp. Pathol. 59:8-12.
27. Simert, G., Nobin, A., Roenmgren, E. and Vang, J. (1978). Neurotransmitter changes in the rat brain after portacaval anastomosis. Eur. J. Surg. Res. 10:73-85.
28. Venero, J.L., Machado, A. and Cano, J. (1991). Turnover of dopamine and serotonin and their metabolites in the striatum of aged rats. J. Neurochem. 56:1949-1948.
29. Wahren, J., Denis, J., Desurmont, P., Eriksson, L.S., Escoffier, J.M., Gauthier, A.P. et al. (1983). Is intravenous administration of branched chain amino acids effective in the treatment of hepatic encephalopathy? A multicentre study. Hepatology 3:475-480.